FDA Clearance Tracker · P860057-S202
Carpentier-Edwards PERIMOUNT Magna Pericardial Aortic Bioprostheses
Last checked: Nov 20, 2026Latest source record: Dec 13, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Dec 13, 2021
Approved
Time to decision
146 days
Received Jul 20, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P860057-S202
- Device name
- Carpentier-Edwards PERIMOUNT Magna Pericardial Aortic Bioprostheses
- Applicant
- Edwards Lifesciences, LLC
- Applicant location
- Irvine, CA
- Received
- Jul 20, 2021
- Decided
- Dec 13, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P860057
Device type
- Device type
- replacement Heart-valve (DYE)
- Device class
- Class III
- Regulation
- 21 CFR 870.3925
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the manufacturing of the Carpentier-Edwards PERIMOUNT Magna Pericardial Aortic Bioprosthesis (MAGNA Model 3300TFX) at the Edwards Cartago, Costa Rica Facility, limited to cleaning and sterilization of components, bioburden reduction, final assembly, terminal liquid sterilization, and packaging and labeling prior to commercial release.
Source documents
Other decisions for Edwards Lifesciences, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PASCAL Precision Transcatheter Valve Repair SystemPMA supplement
P220003-S029 · Decided Oct 20, 2026 · 180 days after receipt · Panel Track
Device type: Tricuspid valve repair device, percutaneously delivered (NPS) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.